These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 1717173)

  • 1. The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
    Circulation; 1991 Oct; 84(4):1831-51. PubMed ID: 1717173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 'Sicilian Gambit'. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. The Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
    Eur Heart J; 1991 Oct; 12(10):1112-31. PubMed ID: 1723682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic drug classifications and the clinician: a gambit in the land of chaos.
    Katritsis D; Camm AJ
    Clin Cardiol; 1994 Mar; 17(3):142-8. PubMed ID: 7513270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can antiarrhythmic agents be selected based on mechanism of action?
    Lau W; Newman D; Dorian P
    Drugs; 2000 Dec; 60(6):1315-28. PubMed ID: 11152014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The working classification of antiarrhythmic drugs based on the pathogenetic approach to treatment of cardiac arrhythmias].
    Lipnitskiĭ TN; Kozlovskiĭ VA
    Lik Sprava; 2002; (8):26-30. PubMed ID: 12669534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classifying antiarrhythmic actions: by facts or speculation.
    Vaughan Williams EM
    J Clin Pharmacol; 1992 Nov; 32(11):964-77. PubMed ID: 1474169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of the Sicilian Gambit.
    Rosen MR
    Eur Heart J; 1995 Aug; 16 Suppl G():32-6. PubMed ID: 8595798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Sicilian Gambit and antiarrhythmic drug development.
    Colatsky TJ
    Cardiovasc Res; 1992 Jun; 26(6):562-5. PubMed ID: 1333361
    [No Abstract]   [Full Text] [Related]  

  • 9. Profiles of aprindine, cibenzoline, pilsicainide and pirmenol in the framework of the Sicilian Gambit. The Guideline Committee for Clinical Use of Antiarrhythmic Drugs in Japan (Working Group of Arrhythmias of the Japanese Society of Electrocardiology).
    Kodama I; Ogawa S; Inoue H; Kasanuki H; Kato T; Mitamura H; Hiraoka M; Sugimoto T
    Jpn Circ J; 1999 Jan; 63(1):1-12. PubMed ID: 10084381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future of antiarrhythmic drugs.
    Darbar D; Roden DM
    Curr Opin Cardiol; 2006 Jul; 21(4):361-7. PubMed ID: 16755206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modernized Classification of Cardiac Antiarrhythmic Drugs.
    Lei M; Wu L; Terrar DA; Huang CL
    Circulation; 2018 Oct; 138(17):1879-1896. PubMed ID: 30354657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of recent ion channel science on the development and use of antiarrhythmic drugs.
    Langan MN
    Curr Cardiol Rep; 1999 Nov; 1(4):302-7. PubMed ID: 10980858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Principles for the classification of anti-arrhythmia agents in cardiac arrhythmias].
    Ravens U
    Z Kardiol; 1992; 81 Suppl 4():119-25. PubMed ID: 1290288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ["Sicilian gambit": pathophysiological approach to drug therapy of arrhythmia (lecture]].
    Sulimov VA
    Ter Arkh; 1999; 71(8):67-74. PubMed ID: 10515042
    [No Abstract]   [Full Text] [Related]  

  • 15. [Classification and mechanism of action of anti-arrhythmia drugs].
    Gasic S
    Wien Med Wochenschr; 1994; 144(14-15):338-42. PubMed ID: 7825324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current classification of anti-arrhythmia agents].
    Weirich J; Wenzel W
    Z Kardiol; 2000; 89 Suppl 3():62-7. PubMed ID: 10810787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concept of the vulnerable parameter: the Sicilian Gambit revisited.
    Rosen MR; Janse MJ
    J Cardiovasc Pharmacol; 2010 May; 55(5):428-37. PubMed ID: 19755918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic drugs and ion channels: have we made the connection?
    Carmeliet E
    J Cardiovasc Electrophysiol; 1999 May; 10(5):755-9. PubMed ID: 10355931
    [No Abstract]   [Full Text] [Related]  

  • 19. Is there a need for new antiarrhythmic drugs?
    Roden DM
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():13-8. PubMed ID: 8734158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study.
    Cimponeriu A; Starmer CF; Bezerianos A
    IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.